JAC Advance Access originally published online on April 21, 2005
Journal of Antimicrobial Chemotherapy 2005 55(6):815-816; doi:10.1093/jac/dki121
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oupjournals.org
Editorial |
Reduced time to publication and increased rejection rate
JAC Editorial Office, 11 The Wharf, 16 Bridge Street, Birmingham B1 2JS, UK
* Corresponding author. Tel: +44-121-633-0415; Fax: +44-121-643-9497; Email: jac@bsac.org.uk
| The first 10% of the full text of this article appears below. |
Introduction
Despite a significant increase in the number of articles handled by the Journal of Antimicrobial Chemotherapy (JAC), improvements in the editorial system and its associated technology have allowed us to improve manuscript processing times significantly. However, the sustained annual increases in submissions to JAC have necessitated a re-evaluation of the criteria for acceptance of manuscripts, and an increase in the rejection rate. We are aware that authors who have had papers rejected may be puzzled when they judge the articles would have been accepted in previous years. This Editorial has been written in the hope that an appreciation of these factors on the part of authors will encourage submission of higher quality articles for consideration by JAC.
Rejection rate
The number of articles submitted to JAC for consideration has approximately doubled over the last 5 years. The Journal
Time to publication
Conclusions